FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug microencapsulation by non-solvent addition; the method is characterised by the fact that the above drugs are presented by cephalosporin preparations, while a coating is human serum albumin precipitated from an aqueous solution by adding methylcarbinol as a non-solvent and acetone at 25°C.
EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2538806C2 |
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2554277C2 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2538668C1 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2539898C2 |
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2545723C2 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538678C2 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538646C1 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2558077C2 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538807C1 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2542417C2 |
Authors
Dates
2014-12-27—Published
2013-05-14—Filed